Journals / MN Kardiyoloji / 2006 / Cilt: 13 - Sayı: 6

Coronary vasospastic disease seen postmenapausal patient

Post menapozal kadın hastada gözlenen koroner vazospastik hastalık

Pages
363–366
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patient had no angina period through one year follow up treated with calcium channel blocker, nitrate and hormone replacement therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronary artery spasm is a dynamic, reversible occlusion caused by the smooth muscle cell construction at the arterial wall.
📊
Key Findings & Data:Postmenapausal patient admitted with a complaint of unstable angina pectoris with electrocardiographic changes and had spasm leading significant stenosis at the left main coronary artery in the performed coronary angiography.
💡
Conclusion & Impact:Patient had no angina period through one year follow up treated with calcium channel blocker, nitrate and hormone replacement therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Postmenopoz · Koroner vazospazm · Orta yaşlı

Abstract

Coronary artery spasm is a dynamic, reversible occlusion caused by the smooth muscle cell construction at the arterial wall. Postmenapausal patient admitted with a complaint of unstable angina pectoris with electrocardiographic changes and had spasm leading significant stenosis at the left main coronary artery in the performed coronary angiography. No plaque formation was seen in the intravascular ultrasound that was done because of residual stenosis after intracoronary nitroglycerin. The patient had no traditional risk factor except menapause. Endothelial protecting effects of estrogen and progesterone decrease during menapause leading to endothelial dysfunction.These suggested coronary vasospastic disease as a result of menapausal changes. Patient had no angina period through one year follow up treated with calcium channel blocker, nitrate and hormone replacement therapy.

Özet

Koroner arter spazmı arterial duvardaki düz kas hücrelerinin konstriksüyonu sonucu oluşan dinamik, reversibl oklüzyondur. Anstabil göğüs ağrısı ve elektrokardiografik değişiklikleri olan postmenopozal hastaya yapılan koroner anjiografide sol ana koroner arterde ciddi darlık yapan spazm izlendi. İntrakoroner nitrogliserin sonrası rezidü kalan hastaya intravasküler ultrasonografi (IVUS) yapıldı ve plak formasyonu izlenmedi. Menopoz dışında risk faktörü olmaması, östrojen ve progesteron hormonlarının menopozda endotelyal koruyucu etkilerinin azalması ile endotelyal disfonksiyon neden olup buna bağlı olarak koroner vazospastik hastalık gelişebileceğini düşündürdü. Kalsiyum kanal blokeri, nitrat ve hormon replasman tedavisi verilen hastanın 1 yıllık takibinde angina atağı tesbit edilmedi.

🔖

Cite This Article

ÖZCAN, T., AKÇAY, B., ACELE, A., SEYİS, A. S., DÖVEN, O. (2006). Coronary vasospastic disease seen postmenapausal patient. MN Kardiyoloji, Cilt: 13 - Sayı: 6, 363–366. https://ajindex.com/articles/297556

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Auch-Schwelk W:(Coronary spasm- A clinically relevant problem ?). Herz 1998; 23:106. Fischel T. Coronary artery spasm after percutaneous transluminal coronary angioplasty: pathophysiology and clinical consequence. Cathet Cardiovasc Diagn 1990; 19:1-3.
  2. Popma J J, Coronary angiography and intravascular ultrasound imaging. In: Zipes D P, Libby P, Bonow R O, Braunwald E. Braunwald's Heart Disease. 7th ed. Pennsylvania, Elsevier saunders 2005:441. Rozenberg V, Nepomnyashc hikh L: Pathomorphology of myocardial bridges and their role in the pathogenesis of coronary disease. Bull Exp Biol Med 2002; 134:593. Barrett-Connor E, Bush TL. Estrogens and coronary heart disease in women. JAMA 1991; 265:1861-7.
  3. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 2001 24; 104:499-503.
  4. Mendelsohn ME, Karas, RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340:1801-11.
  5. Kawano H, Motoyama T, Hirai N, Kugiyama K, Ogawa H, Yasue H. Estradiol Supplementation Suppresses Hyperventila- tion-lnduced Attacks in Postmenopausal Women With Variant Angina. JACC 2001; 37:735-40.